Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers

IPI-145 ADME and Absolute Bioavailability Study

NCT01836861 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

NCT02099071 ·Status: COMPLETED ·Phase: PHASE1

A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects

NCT03884491 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment

NCT02170220 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

NCT06973005 ·Status: COMPLETED ·Phase: PHASE1

Study to Determine the Absorption, Metabolism, and Excretion of [14C]LX4211 in Healthy Male Subjects

NCT01818232 ·Status: COMPLETED ·Phase: PHASE1

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

NCT01157104 ·Status: COMPLETED ·Phase: PHASE1

A Study in Healthy Men to Test How BI 1291583 is Processed in the Body

NCT05833035 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects

NCT01433458 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment

NCT03423446 ·Status: COMPLETED ·Phase: PHASE1

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

NCT00619931 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers

NCT02929342 ·Status: COMPLETED ·Phase: PHASE1

This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body

NCT03382509 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment

NCT03160014 ·Status: UNKNOWN ·Phase: PHASE1

A Study in Healthy Men to Test How BI 730357 is Processed by the Body

NCT03664011 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults

NCT05804279 ·Status: COMPLETED ·Phase: PHASE1

Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants

NCT03961997 ·Status: COMPLETED ·Phase: PHASE1

A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants

NCT04075409 ·Status: COMPLETED ·Phase: PHASE1

A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

NCT04193436 ·Status: COMPLETED ·Phase: PHASE1

A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001

NCT03150498 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers

NCT02259842 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ir-CPI in Healthy Male Subjects

NCT04653766 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers

NCT02471690 ·Status: COMPLETED ·Phase: PHASE1

A Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled Risdiplam (RO7034067) in Healthy Male Participants

NCT03036501 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.

NCT02151994 ·Status: COMPLETED ·Phase: PHASE1